| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1312151
[patent_doc_number] => 06613803
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/421403
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 20040
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613803.pdf
[firstpage_image] =>[orig_patent_app_number] => 09421403
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421403 | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof | Oct 20, 1999 | Issued |
Array
(
[id] => 1312151
[patent_doc_number] => 06613803
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/421403
[patent_app_country] => US
[patent_app_date] => 1999-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 20040
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613803.pdf
[firstpage_image] =>[orig_patent_app_number] => 09421403
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/421403 | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof | Oct 20, 1999 | Issued |
Array
(
[id] => 1253554
[patent_doc_number] => 06670348
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Methods and compositions for destruction of selected proteins'
[patent_app_type] => B1
[patent_app_number] => 09/403434
[patent_app_country] => US
[patent_app_date] => 1999-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 6035
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670348.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403434
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403434 | Methods and compositions for destruction of selected proteins | Oct 19, 1999 | Issued |
Array
(
[id] => 4277374
[patent_doc_number] => 06281215
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => '4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications'
[patent_app_type] => 1
[patent_app_number] => 9/331155
[patent_app_country] => US
[patent_app_date] => 1999-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3497
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281215.pdf
[firstpage_image] =>[orig_patent_app_number] => 331155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/331155 | 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications | Oct 19, 1999 | Issued |
Array
(
[id] => 4409952
[patent_doc_number] => 06300339
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-09
[patent_title] => 'Compounds, their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 9/420379
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12218
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 988
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/300/06300339.pdf
[firstpage_image] =>[orig_patent_app_number] => 420379
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/420379 | Compounds, their preparation and use | Oct 18, 1999 | Issued |
Array
(
[id] => 4418642
[patent_doc_number] => 06194409
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Heterocyclic derivatives and their use as antithrombotic agents'
[patent_app_type] => 1
[patent_app_number] => 9/403327
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61154
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 640
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194409.pdf
[firstpage_image] =>[orig_patent_app_number] => 403327
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403327 | Heterocyclic derivatives and their use as antithrombotic agents | Oct 18, 1999 | Issued |
Array
(
[id] => 1387488
[patent_doc_number] => 06552193
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-22
[patent_title] => 'Chloropyrimidine intermediates'
[patent_app_type] => B1
[patent_app_number] => 09/419416
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7664
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/552/06552193.pdf
[firstpage_image] =>[orig_patent_app_number] => 09419416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/419416 | Chloropyrimidine intermediates | Oct 14, 1999 | Issued |
Array
(
[id] => 4360472
[patent_doc_number] => 06255319
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => '5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands'
[patent_app_type] => 1
[patent_app_number] => 9/403003
[patent_app_country] => US
[patent_app_date] => 1999-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6491
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255319.pdf
[firstpage_image] =>[orig_patent_app_number] => 403003
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403003 | 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands | Oct 14, 1999 | Issued |
Array
(
[id] => 4420391
[patent_doc_number] => 06194567
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-27
[patent_title] => 'Halogenating agent and process for halogenating hydroxyl group'
[patent_app_type] => 1
[patent_app_number] => 9/402863
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6772
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/194/06194567.pdf
[firstpage_image] =>[orig_patent_app_number] => 402863
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/402863 | Halogenating agent and process for halogenating hydroxyl group | Oct 12, 1999 | Issued |
Array
(
[id] => 1546508
[patent_doc_number] => 06444817
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Thrombin inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/414681
[patent_app_country] => US
[patent_app_date] => 1999-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41519
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444817.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414681
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414681 | Thrombin inhibitors | Oct 7, 1999 | Issued |
Array
(
[id] => 4363430
[patent_doc_number] => 06255512
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators'
[patent_app_type] => 1
[patent_app_number] => 9/414977
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7738
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255512.pdf
[firstpage_image] =>[orig_patent_app_number] => 414977
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414977 | Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators | Oct 6, 1999 | Issued |
Array
(
[id] => 1494731
[patent_doc_number] => 06342532
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-29
[patent_title] => 'Inorganic ion receptor active compounds'
[patent_app_type] => B1
[patent_app_number] => 09/415179
[patent_app_country] => US
[patent_app_date] => 1999-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12385
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/342/06342532.pdf
[firstpage_image] =>[orig_patent_app_number] => 09415179
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/415179 | Inorganic ion receptor active compounds | Oct 5, 1999 | Issued |
Array
(
[id] => 4252092
[patent_doc_number] => 06207663
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Vitronectin receptor antagonists, their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 9/412331
[patent_app_country] => US
[patent_app_date] => 1999-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32071
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2380
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207663.pdf
[firstpage_image] =>[orig_patent_app_number] => 412331
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/412331 | Vitronectin receptor antagonists, their preparation and use | Oct 4, 1999 | Issued |
Array
(
[id] => 1453895
[patent_doc_number] => 06462034
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Local anesthetic compounds and uses'
[patent_app_type] => B1
[patent_app_number] => 09/411331
[patent_app_country] => US
[patent_app_date] => 1999-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 42622
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462034.pdf
[firstpage_image] =>[orig_patent_app_number] => 09411331
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/411331 | Local anesthetic compounds and uses | Sep 30, 1999 | Issued |
Array
(
[id] => 4368167
[patent_doc_number] => 06274577
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Benzodiazepines'
[patent_app_type] => 1
[patent_app_number] => 9/408258
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12045
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274577.pdf
[firstpage_image] =>[orig_patent_app_number] => 408258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408258 | Benzodiazepines | Sep 28, 1999 | Issued |
Array
(
[id] => 4156689
[patent_doc_number] => 06124471
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'Phenyldiboronic acid reagents and complexes'
[patent_app_type] => 1
[patent_app_number] => 9/407673
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13339
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124471.pdf
[firstpage_image] =>[orig_patent_app_number] => 407673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/407673 | Phenyldiboronic acid reagents and complexes | Sep 27, 1999 | Issued |
Array
(
[id] => 4260578
[patent_doc_number] => 06204269
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-20
[patent_title] => 'Fungicidal trifluoromethylalkylamino-triazolopyrimidines'
[patent_app_type] => 1
[patent_app_number] => 9/406574
[patent_app_country] => US
[patent_app_date] => 1999-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6390
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/204/06204269.pdf
[firstpage_image] =>[orig_patent_app_number] => 406574
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406574 | Fungicidal trifluoromethylalkylamino-triazolopyrimidines | Sep 23, 1999 | Issued |
| 09/405524 | SUBSTITUTED N-BENZYL-N-PHENYL AMINOALCOHOL COMPOUNDS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Sep 22, 1999 | Abandoned |
| 09/404638 | SUBSTITUTED TERTIARY HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Sep 22, 1999 | Abandoned |
| 09/401916 | SUBSTITUTED N-ALIPHATIC-N-AROMATICTERTIARY-HETEROALKY LAMINES USEFUL FOR INHIBITING CHOLESTERY ESTER RTRANSFER PROTEIN ACTIVITY | Sep 22, 1999 | Abandoned |